Inspire Medical Posts 84-Cent Quarterly Loss Per Share
INSP sits 73% above its 52-week low of $38.91.
Summary
Inspire Medical Systems reported a third-quarter loss of 84 cents per share on revenue of $206.7M. That is a swing to a loss for a company whose last full-year filing showed a significant net income increase, so the quarterly result marks a sharp reversal in profitability. With a market cap near $1.9 billion and the stock at $67.21, a per-share loss of this magnitude is material to the earnings story. The only recent filings were routine insider sales under pre-existing plans, so this is the first hard fundamental data point in weeks. Looking ahead, the company narrowed its 2026 view to revenue of $850M-$860M, sees a 2026 loss per share of 10 cents to 36 cents, and sees 2026 adjusted EPS of $1.20 to $1.40.
At the time of this announcement, INSP was trading at $67.21 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $38.91 to $147.03. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.